Showing 351-360 of 1319 results for "".
Headache Horizons: Tuning in to Psychedelics for Treatment of Suicide Headaches
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-tuning-in-to-psychedelics-for-treatment-of-suicide-headaches/30174/Neurologists need to understand the phenomenon of using psychedelic drugs for cluster-busting and advocate for appropriate research.Late in the Game: Concussion, CTE, and the Role of the Neurologist
https://practicalneurology.com/diseases-diagnoses/tbi/late-in-the-game-concussion-cte-and-the-role-of-the-neurologist/30488/A sports neurology expert shares insights on the science of concussion, common misperceptions about CTE, and the dire need for more education and research funding.Headache Horizons: The Study and Use of Psychedelics in Cluster Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-the-study-and-use-of-psychedelics-in-cluster-headache/32032/Psychedelics have a history of use in headache disorders and evidence exists for their therapeutic benefit in cluster headache.Poststroke Recrudescence:
Current Evidence and Considerations for Clinical Practicehttps://practicalneurology.com/diseases-diagnoses/stroke/poststroke-recrudescencebrcurrent-evidence-and-considerations-for-clinical-practice/32073/Despite the high prevalence of recrudescence after stroke and the importance of correct identification of recurrent cerebral ischemia, poststroke recrudescence is poorly understood.Point/Counterpoint: Food and Drug Administration Multiple Sclerosis Categorization Changes
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pointcounterpoint-food-and-drug-administration-multiple-sclerosis-categorization-changes/31633/Are the changes a step forward or a step back?The Brain Activity Map: Answers for Alzheimer's and More?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-brain-activity-map-answers-for-alzheimers-and-more/30733/An ambitious new research goal seeks to better understand how the brain works. Will the project succeed, and what will it actually show?Ocrelizumab and the Next Phase in Multiple Sclerosis Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ocrelizumab-and-the-next-phase-in-multiple-sclerosis-therapy/30505/Advances in immune therapy may change how scientists and clinicians understand neurodegenerative components of MS.Viewpoints: Annoyances are Unavoidable; Frustration Isn't
https://practicalneurology.com/columns/practice-management/viewpoints-annoyances-are-unavoidable-frustration-isnt/30800/More research should be devoted to what bugs physicians and detracts from the care of our patients.Headache Horizons: Headache in the CGRP Era
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-headache-in-the-cgrp-era/30118/There are knowns, unknowns, and bogeymen.Nonpharmacologic Approaches to Adverse Behaviors Associated with Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/nonpharmacologic-approaches-to-adverse-behaviors-associated-with-dementia/32015/Commonsense approaches to frequently occurring dementia-related adverse behaviors.